# Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures

> **NCT04769713** · PHASE4 · UNKNOWN · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 80 (estimated)

## Conditions studied

- Pain Control
- Liver Cancer

## Interventions

- **PROCEDURE:** Hepatic Hilar Nerve Block Needle placement
- **DRUG:** Injection of Ropivacaine in the hepatic hilum for the hepatic hilar nerve block
- **DRUG:** Injection of normal saline in the hepatic hilum for the sham procedure

## Key facts

- **NCT ID:** NCT04769713
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-23
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04769713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04769713, "Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04769713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*